Brief: Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan

Can Fite Biopharma

18/12/2023 12:03

Dec 18 (Reuters) - Can Fite Biopharma Ltd  CANF.TA :
    * CAN-FITE RECEIVED FDA POSITIVE RESPONSE TO PSORIASIS
PEDIATRIC
PLAN
    * CAN FITE BIOPHARMA - PLAN SUBMITTED TO ALLOW ENROLLMENT OF
CHILDREN WITH PSORIASIS TO CAN-FITE'S UPCOMING PHASE 3 PIVOTAL
CLINICAL PSORIASIS STUDIES

Source text for Eikon:  ID:nBw8mwnMYa 
Further company coverage:  CANF.TA 

 ((Reuters.Briefs@thomsonreuters.com;))